A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Clinical trial NCT06858397 · RECRUITING
Trial details
- NCT number
- NCT06858397
- Sponsor
- GC Biopharma Corp
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-14
- Primary completion
- 2028-08-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.